Welcome to LookChem.com Sign In|Join Free

CAS

  • or

199613-48-4

Post Buying Request

199613-48-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

199613-48-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 199613-48-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,9,6,1 and 3 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 199613-48:
(8*1)+(7*9)+(6*9)+(5*6)+(4*1)+(3*3)+(2*4)+(1*8)=184
184 % 10 = 4
So 199613-48-4 is a valid CAS Registry Number.

199613-48-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name (5S)-5-[tert-butyl(dimethyl)silyl]oxycyclohex-2-en-1-one

1.2 Other means of identification

Product number -
Other names (5S)-5-(tert-butyldimethylsiloxy)cyclohex-2-enone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:199613-48-4 SDS

199613-48-4Relevant articles and documents

Enantioselective Desymmetrization of cis-3,5- O-Arylidenecyclohexanones Catalyzed by Cinchona-Derived Quaternary Ammonium Salts

Cortigiani, Mauro,Gillick Healy, Malachi,Mereu, Andrea,Adamo, Mauro F. A.

, p. 4112 - 4119 (2019/04/30)

An enantioselective protocol for the desymmetrization of cis-3,5-O-arylidenecyclohexanones has been developed that proceeded under the catalysis of readily available and inexpensive Cinchona-derived quaternary ammonium salts. The synthetic relevance of the methodology was exemplified by the synthesis of a key intermediate that could be used in the preparation of the active pharmaceutical ingredient, paricalcitol (Zemplar).

Synthesis of diastereomers of 1,3-cis-25-dihydroxy-19-norvitamin D3

Usuda, Kosuke,Biswas, Tanima,Yamaguchi, Takuya,Akagi, Yusuke,Yasui, Koji,Uesugi, Motonari,Shimizu, Isao,Hosokawa, Seijiro,Nagasawa, Kazuo

, p. 1190 - 1195 (2016/08/11)

1β,3β,25-Dihydroxy-19-norvitamin D3 (4a) and 1α,3α,25-dihydroxy-19-norvitamin D3 (4b) were synthesized by employing a new A-ring synthon, (1R,3S)-3-((tert-butyldimethylsilyl)oxy)-5-oxocyclohexyl benzoate (19), which was derived from D-(-)-quinic acid in 12 steps. The A-ring was coupled with the circular dichroism (CD) ring by means of Julia-Kocienski olefination to construct the diene unit. The structures of the products were confirmed by 1H-NMR and nuclear Overhauser effect (NOE) experiments.

Total synthesis of (+)-rugulosin and (+)-2,2′-epi-cytoskyrin A through cascade reactions

Nicolaou,Lim, Yee Hwee,Papageorgiou, Charles D.,Piper, Jared L.

, p. 7917 - 7921 (2007/10/03)

(Chemical Equation Presented) The cytoskyrin cascade: The total syntheses of the bisanthraquinones 2 (+)-2,2′-epi-cytoskyrin A (R2 = OMe) and (+)-rugulosin (R2 = Me) has been achieved through a cascade sequence from anthradihydroquin

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 199613-48-4